Impact Evaluation of a Targeted mHealth Intervention to Improve Uptake of Postpartum Contraception in Kenya

NCT06266780 | Recruiting

• 1 other identifier: P1473-2023
• Study Type: interventional
• Target: 4,190
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to explore approaches to improve postpartum contraceptive counseling, information, and uptake through a collaboration between the Harvard Chan School, Rutgers School of Public Health, Jacaranda Health, Jhpiego, and IPSOS, leveraging an existing mobile health platform for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals. Jacaranda's PROMPTS mHealth platform has reached over two million pregnant women and new mothers, providing them with needed, tailored information about prenatal and postpartum health along with access to a mobile helpdesk to triage users' questions. Using a targeted human-centered-design process with early postpartum mothers, we developed targeted messaging around family planning and contraceptive method options, with the goal of integrating this new content into Jacaranda's PROMPTS platform. We will conduct a randomized controlled trial with pregnant women engaged with the PROMPTS platform to determine the impact of the intervention package on information and utilization of postpartum contraception. If proven effective, the results of this intervention will be integrated into Jacaranda's PROMPTS system at full scale.

Conditions

Postpartum Family Planning

Keywords

Maternal Health; Postpartum Health; Contraception; Family Planning; Birth Spacing

Outcome Measures

Primary Outcomes (2)

• Use of postpartum family planning at 3 months

  The outcome is a binary variable, set to 1 if a participant reports using any modern family planning method (including Lactational Amenorrhea Method (LAM)) at the time of the survey. The modern methods considered will include sterilization (both male and female), implants, Intrauterine Device (IUD), injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam/jelly, and LAM.

  3 months

• Use of postpartum family planning at 6 months

  The outcome is a binary variable, assigned a value of 1 if a participant reports using any modern family planning method, excluding LAM, at the time of the survey. The modern methods considered include sterilization (both male and female), implant, IUD, injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam, and jelly.

  6.5 months

Secondary Outcomes (13)

• Knowledge of return to fertility

  3 months postpartum

• Knowledge of safe birth spacing

  3 months postpartum

• Knowledge of lactational amenorrhea (LAM) method

  3 months postpartum

• Intention to continue family planning method

  3 and 6.5 months postpartum

• Intended duration of continued family planning method use

  3 and 6.5 months postpartum

Other Outcomes (2)

• Quality of helpdesk team in counselling on family planning

  6.5 months postpartum

• Quality of message flow on method selection

  6.5 months postpartum

Study Arms (2)

Intervention Group

EXPERIMENTAL

Group receiving enhanced package of postpartum family planning support

Behavioral: PROMPTS Enhanced Family Planning Counselling

Control Group

NO INTERVENTION

Group receiving basic postpartum family planning information

Interventions

PROMPTS Enhanced Family Planning Counselling BEHAVIORAL

Based on a targeted human-centered-design process with pregnant and early postpartum mothers, the intervention consists of informative messages, counselling and reminders regarding postpartum family planning and birth spacing, leveraging an existing mobile health platform (PROMPTS) for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals method options. The intervention includes several features: activation of family planning discussions between pregnant and postpartum women and their health care providers, information provision, method selection support to help women choose their preferred method, and reminders to follow-up. The key feature is to help women make an informed plan about family planning in the prenatal or early postpartum period and follow through with this plan.

Intervention Group

Eligibility Criteria

• Age: 15 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 15 and over,
• Pregnant at 7-8 months gestation,
• Consented to be enrolled in the PROMPTS text-messaging platform and who have provided informed consent to be part of this research study
• Have access to a mobile phone

You may not qualify if:

• None

Sponsors & Collaborators

• Jacaranda Health: lead
• Harvard School of Public Health (HSPH): collaborator
• Jhpiego: collaborator
• IPSOS: collaborator

Study Sites (1)

Jacaranda Health

Nairobi, 00000, Kenya

RECRUITING

Study Officials

• Anneka Wickramanayake, MPH

  Jacaranda Health

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Anneka Wickramanayake, MPH

CONTACT

254 70 0164229; awickramanayake@jacarandahealth.org

Jessica Cohen, Ph.D

CONTACT

617-432-7577; cohenj@hsph.harvard.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: BASIC SCIENCE
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 11, 2024
• First Posted: February 20, 2024
• Study Start: February 2, 2024
• Primary Completion: August 30, 2024
• Study Completion: December 31, 2024
• Last Updated: February 20, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

KE (1)